Cargando…
Updates on CRISPR-based gene editing in HIV-1/AIDS therapy
Although tremendous efforts have been made to prevent and treat HIV-1 infection, HIV-1/AIDS remains a major threat to global human health. The combination antiretroviral therapy (cART), although able to suppress HIV-1 replication, cannot eliminate the proviral DNA integrated into the human genome an...
Autores principales: | Zhang, Zhihao, Hou, Wei, Chen, Shuliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922418/ https://www.ncbi.nlm.nih.gov/pubmed/35234622 http://dx.doi.org/10.1016/j.virs.2022.01.017 |
Ejemplares similares
-
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
por: Xiao, Qiaoqiao, et al.
Publicado: (2019) -
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
por: Hou, Panpan, et al.
Publicado: (2015) -
Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
por: Zhang, Huimin, et al.
Publicado: (2021) -
CRISPR: a journey of gene-editing based medicine
por: Golkar, Zhabiz
Publicado: (2020) -
Challenges of CRISPR-Based Gene Editing in Primary T Cells
por: Rezalotfi, Alaleh, et al.
Publicado: (2022)